We are excited to announce the launch of the newĀ TrialX.com, a refreshed digital home highlighting our unified,Ā enterprise-grade global platform designed to accelerateĀ clinical trial recruitment and engagement. Driven by a mission of innovation since 2008, TrialX provides aĀ single “command center” that replaces fragmented tools, allowing sponsors to bring all vendors and sites into one ecosystem while maintaining total ownership of their recruitment data. Our updated site showcases how we are moving the industry forward withĀ AI-assisted trial matching, global clinical trial enrollment, andĀ specialized remote research solutions that scale from Earth to space.Ā VisitĀ trialx.com to see how we are building a better way to manage clinical trials.
Whatās New at TrialX! š
āļø PRODUCTĀ HIGHLIGHTS
We recently launched powerful automation and outreach features in ourĀ patient recruitment management platform. With Smart Automations, study teams can now trigger email notifications before, after, or immediately following predefined events, with the ability to localize content by selecting specific country and language variants so patients receive messages in their preferred tongue. In addition, the updated outreach workflow provides study teamsĀ with configurable and flexible email templates. Researchers can easily build templates from scratch or modify existing default templates as a base to create user-specific versions tailored to their individual workflows.
We are proud to support Montefiore Medical Center and the University of Cincinnati in buildingĀ the FORETELL-Epilepsy app, anĀ NIH-funded initiativeĀ to advance seizure forecasting and improve patient care. The app enables adults living with epilepsy to contribute real-world data through daily diaries of seizures, mood, and stress, and integrates with wearable devices to track heart rate and sleep. It is now live on app stores, with enrollment underway. We are glad and honored that the investigators and study team felt supported throughout the process, sharing:Ā āI wanted to take a moment to express our sincere appreciation for the time and effort TrialX has dedicated to supporting us with the apps and troubleshooting whenever issues arise.āĀ
Weāre honored toĀ power the ALS Networkās Trial Finder, an AI-driven platform that helps individuals easily discover clinical trials for ALS and related motor neuron diseases. The tool offers a personalized, user-friendly experience with guided questions, smart filters, and clear trial summariesāconnecting patients to relevant studies and keeping them informed through a volunteer registry.Ā Read more.
Space missions demand health monitoring in environments with limited connectivity and extreme conditionsāwhere traditional tools often fall short. TrialX Space Health Systems is an offline-capable, AI-powered platform that collects and analyzes diverse datasets, from wearables to genomics, even beyond Earthās grid. Remote health research is possible, wherever the mission goes.Ā Learn More.
š„Ā RECENT WEBINARĀ
Patients searching for clinical trials are often met with dense, technical language designed for scientific audiences, not for people trying to decide whether a study is right for them. If youāre part of a pharma, academic medical center, or patient advocacy organization looking to make trial information more accessible, we invite you toĀ watch this webinar where we shareĀ how AI, guided by thoughtful prompt design, can turn technical listings into clear, patient-friendly summariesāwithout losing accuracy. You will also hear perspectives on usingĀ AI simplified listingsĀ fromĀ Krista Goedel of Sanofi.
šŗ MEDIA & PRESS
Our Co-founder & CEO, Sharib Khan, was featured inĀ Clinical Research NewsĀ in the article āSpace Health Research Could Rack Up Many Earthly Dividends.ā The piece highlights how our space health research innovations – developed in collaboration with the Translational Research Institute for Space Health (TRISH), are enabling the collection of vital human health data from commercial spaceflights, with implications that extend beyond astronauts to advance clinical research on Earth.Ā Read the full story.
RECENT CURETALKSĀ 
In this CureTalks session, world-renowned geneticist and cardiologist Dr. Kiran Musunuru and CEO of Global Genes, Charlene Son Rigby discuss how breakthroughs in gene editing are transforming careāfrom lowering cholesterol to developing personalized therapies for rare genetic disordersāand what this means for the future of precision medicine.Ā Watch here.
š§¬Ā FEATURED CLINICAL STUDIES
Powered by TrialX
Brain Responses to Robot Movements:Ā Ā This Penn Medicine study explores how the brain responds to watching and imitating movements performed by humans and robots. Researchers are assessing how these insights could improve robotic and telehealth tools for stroke rehabilitation and motor recovery.
The BURST Study:Ā Researchers at Indiana University are investigating how the transition from elementary to middle school affects children’s cognitive development, social relationships, and emotional well-being. They aim to explore how these important changes influence development during early adolescence.
Investigational Treatment for Ulcerative Colitis:Ā This global Phase 2 study evaluates an investigational oral therapy for adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. Researchers are assessing whether the treatment can reduce inflammation, achieve clinical remission, and improve quality of life.
The BLAAC PD study: Part of the Global Parkinson’s Genetics Program implemented by The Michael J. Fox Foundation for Parkinson’s Research, this study is collecting blood samples and health information from Black and African American individuals with and without Parkinson’s disease to better understand its genetic causes. By contributing to a global research effort, the study aims to improve future diagnosis and treatment.
šĀ AROUND THE WEB Ā
šĀ 5 FDA decisions to watchĀ in the third quarter of 2026.
š§ Ā A “brain freeze” treatmentĀ could become the next breakthrough in stroke care.
āļøĀ Ways to make clinical trials more informativeĀ and reduce research waste
š America at 500: Where will we be in space in 2276?
š¦ Emerging nanotech could be theĀ future of wound healing.
ā¼ļø NOTEWORTHY
šĀ TEAM UPDATES
Our business development team attended the Dan Diaz Biotech Breakfast Club at the Pennsylvania Biotechnology Center last week. The monthly gathering brought together members of the regional life sciences community, providing an opportunity to exchange ideas and connect with emerging biotech companies and industry leaders.
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on AI powered solutions to simplify global patient recruitment management and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!
All the best,
Team TrialX
